TOPLINE: Immune-related adverse events (irAEs) were associated with significantly improved progression-free survival (PFS) and overall survival (OS) in patients with extensive-stage small cell lung cancer (SCLC) who received chemoimmunotherapy compared with that in those who did not experience such events. METHODOLOGY: Researchers conducted a retrospective analysis of 399 consecutive patients (median age...
.png)
2488 Grand Concourse, suite 314, Bronx NY 10458
+1786-550-1661
info@holdingsolutioninc.com
Copyright © 2023 holdingsolutioninc. All Rights Reserved
